General Information of the Compound
| Compound ID |
CP0526927
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-methyl-N-[N'-(2-phenylethyl)carbamimidoyl]benzamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
BDBM50107044
CHEMBL107354
N-(4-Methyl-benzoyl)-N'-phenethyl-guanidine
SCHEMBL4629436
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H19N3O
|
||||||||||||||||||
| Molecular Weight |
281.359
|
||||||||||||||||||
| Canonical SMILES |
Cc1ccc(cc1)C(=O)NC(N)=NCCc1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H19N3O/c1-13-7-9-15(10-8-13)16(21)20-17(18)19-12-11-14-5-3-2-4-6-14/h2-10H,11-12H2,1H3,(H3,18,19,20,21)
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZVURELUSYUBEQF-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03022, Sodium channel protein type 2 subunit alpha
Protein ID: PT01105, Sodium channel protein type 5 subunit alpha
Clinical Information about the Compound